Concentrum Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-36,076
Closed -$1.75M 67
2023
Q3
$1.75M Buy
36,076
+2,361
+7% +$126K 1.06% 18
2023
Q2
$1.9M Buy
33,715
+326
+1% +$18K 1.22% 16
2023
Q1
$1.8M Buy
33,389
+269
+0.8% +$14.3K 1.34% 15
2022
Q4
$1.74M Sell
33,120
-5,456
-14% -$277K 1.56% 17
2022
Q3
$1.82M Sell
38,576
-15,208
-28% -$789K 1.59% 16
2022
Q2
$2.71M Buy
53,784
+951
+2% +$51.8K 2.23% 12
2022
Q1
$3.22M Sell
52,833
-1,677
-3% -$100K 2.01% 12
2021
Q4
$3.59M Buy
54,510
+35,021
+180% +$2.24M 1.87% 14
2021
Q3
$1.22M Buy
+19,489
New +$1.24M 0.77% 25
2021
Q1
Sell
-54,432
Closed -$2.97M 56
2020
Q4
$2.97M Buy
54,432
+5,280
+11% +$276K 2.34% 13
2020
Q3
$2.46M Buy
49,152
+6,834
+16% +$331K 2.34% 9
2020
Q2
$1.87M Buy
+42,318
New +$1.81M 1.89% 11

Other funds holding IHI

Concentrum Wealth Management's IHI Position: Q4 2023 in Review

Concentrum Wealth Management sold out of iShares US Medical Devices ETF (IHI) in Q4 2023, closing a stake of 36,076 shares — an estimated $1.75M sold.

Concentrum Wealth Management first reported a position in IHI in Q2 2020 and held it in 12 quarters. The position peaked at $3.59M in Q4 2021. 574 funds tracked by Wall St. Rank hold IHI as of Q4 2023.

  • Concentrum Wealth Management reported no remaining iShares US Medical Devices ETF position as of Q4 2023 after selling out during the quarter.
  • Concentrum Wealth Management sold 36,076 iShares US Medical Devices ETF shares in Q4 2023, an estimated $1.75M.
  • Concentrum Wealth Management first reported a position in iShares US Medical Devices ETF in Q2 2020 and held it in 12 quarters.
  • Concentrum Wealth Management's iShares US Medical Devices ETF position peaked at $3.59M in Q4 2021.
  • 574 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2023.

Based on Concentrum Wealth Management's 13F filing for Q4 2023, filed 6 Feb 2024.